Breaking News on Contract Research, Manufacturing & Clinical Trials

Top Headlines

Biomarkers triple clinical trial success rate, says report

A recent study of clinical drug development success rates found that biomarker-enabled drug programs are three times more likely to reach approval.

Bioclinica launches CTMS for CROs and mid-market biopharma

As more CROs look to divest in-house clinical trial technologies, Bioclinica has released a new Clinical Trial Management System (CTMS) sized specifically for smaller organizations.

Xellia starts work on testing lab at Hungary API plant citing growing demand

Xellia Pharmaceuticals has started building a stability and release-testing unit at its API facility in Budapest, Hungary that is designed to support increased output.

ClinTec 'on track' with growth strategy as new offices open in Spain

ClinTec International has opened two new offices in Spain as it prepares for an expanding local clinical trial portfolio and larger outsourcing engagements in the country.

Amulet buys SynterActHCR from Gryphon

Amulet Capital Partners has bought SynteractHCR in its first acquisition in the contract research sector.


By Reading Scientific Services Ltd.

Content Provided by Reading Scientific Services Ltd.

Method development – why it matters to get it right

In an industry that is seeing increasing levels of outsourcing, the contract research organisation (CRO) needs to have proven experience in both the pragmatism and flexibility of method development and a regulatory background in validation.

By World Courier

Content Provided by World Courier

World Courier shares its insights on successful importation of clinical trial drugs into China

Getting a clinical trial drug into China is a complex business. Any discrepancies in paperwork or the physical shipment can lead to delays at customs or China Inspection & Quarantine. World Courier shares its experience for successful shipping.

By Reading Scientific Services Ltd.

Content Provided by Reading Scientific Services Ltd.

Impurity isolation and sample purification

During a manufacturing process unexpected and unknown impurities may arise in a sample. It is important that such impurities are isolated and identified.

By Catalent

Content Provided by Catalent

Demand led supply: A novel clinical supply approach tailored to today’s trials

The nature and scope of clinical research has changed significantly over the past decade. Studies are more complex, globalized and patient-centric than ever. Yet, the processes used to package and ship study drugs to trial sites are stuck in an earlier era, depriving sponsors of clinical supply models with the flexibility, speed and efficiency their programs demand. Now, that may be about to change with the advent of demand led supply (DLS), a clinical supply model tailored to today’s trials.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...